Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Submitted by
admin
on October 31, 2016 - 9:40am
Source:
Fierce Pharma
News Tags:
Biogen
Tecfidera
Amgen
Enbrel
drug pricing
Headline:
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Do Not Allow Advertisers to Use My Personal information
